Drug Type siRNA |
Synonyms CCT 617, CCT617 |
Target |
Action inhibitors |
Mechanism TLE3 inhibitors(TLE family member 3, transcriptional corepressor inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Obesity | Preclinical | Canada | 01 Feb 2025 |





